Clinical Pharmacokinetics

4.0(top 10%)

impact factor

3.3K(top 5%)

papers

226.6K(top 2%)

citations

209(top 1%)

h-index

4.4(top 10%)

extended IF

3.7K

all documents

237.4K

doc citations

306(top 2%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Pharmacokinetics of Pegylated Liposomal Doxorubicin	Clinical Pharmacokinetics	2003	1,373
2	Pharmacokinetics and Pharmacodynamics of Cannabinoids	Clinical Pharmacokinetics	2003	1,148
3	Understanding the Dose-Effect Relationship	Clinical Pharmacokinetics	1981	999
4	Clinical Pharmacology of Tramadol	Clinical Pharmacokinetics	2004	995
5	Clinical Pharmacokinetics of Metformin	Clinical Pharmacokinetics	2011	952
6	Clinical Pharmacology of 5-Fluorouracil	Clinical Pharmacokinetics	1989	800
7	Pegylation	Clinical Pharmacokinetics	2001	789
8	Role of P-Glycoprotein in Pharmacokinetics	Clinical Pharmacokinetics	2003	783
9	Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism	Clinical Pharmacokinetics	2002	780
10	Sex Differences in Pharmacokinetics and Pharmacodynamics	Clinical Pharmacokinetics	2009	777
11	Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition	Clinical Pharmacokinetics	2000	758
12	Clinical Pharmacokinetics of Mycophenolate Mofetil	Clinical Pharmacokinetics	1998	745
13	Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation	Clinical Pharmacokinetics	2004	728
14	Quantification of Lean Bodyweight	Clinical Pharmacokinetics	2005	726
15	Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine	Clinical Pharmacokinetics	2017	723
16	Clinical Pharmacokinetics of Tacrolimus	Clinical Pharmacokinetics	1995	681
17	Inhibition and Induction of Cytochrome P450 and the Clinical Implications	Clinical Pharmacokinetics	1998	680
18	Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids	Clinical Pharmacokinetics	2005	678
19	Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate	Clinical Pharmacokinetics	2010	664
20	Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections	Clinical Pharmacokinetics	2004	653
21	Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions	Clinical Pharmacokinetics	1997	643
22	Pharmacokinetic Interactions with Rifampicin	Clinical Pharmacokinetics	2003	619
23	Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance	Clinical Pharmacokinetics	2009	611
24	Effect of Obesity on the Pharmacokinetics of Drugs in Humans	Clinical Pharmacokinetics	2010	610
25	Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies	Clinical Pharmacokinetics	2010	583
26	Drug Interactions with Tobacco Smoking	Clinical Pharmacokinetics	1999	577
27	Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran Etexilate	Clinical Pharmacokinetics	2008	569
28	Clinical Pharmacokinetics of Imatinib	Clinical Pharmacokinetics	2005	562
29	Pregnancy-Induced Changes in Pharmacokinetics	Clinical Pharmacokinetics	2005	547
30	Enterohepatic Circulation	Clinical Pharmacokinetics	2002	537
31	Effects of Obesity on Pharmacokinetics	Clinical Pharmacokinetics	2000	536
32	Clinical Pharmacokinetics of Metformin	Clinical Pharmacokinetics	1996	522
33	Interindividual Variability of the Clinical Pharmacokinetics of Methadone	Clinical Pharmacokinetics	2002	514
34	Pharmacological Effects of Formulation Vehicles	Clinical Pharmacokinetics	2003	514
35	Drug Transfer and Metabolism by the Human Placenta	Clinical Pharmacokinetics	2004	512
36	A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin	Clinical Pharmacokinetics	2010	502
37	Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Solid Organ Transplant Recipients	Clinical Pharmacokinetics	2007	490
38	Cytochrome P450 3A	Clinical Pharmacokinetics	1999	489
39	Clinical Pharmacokinetics of Atorvastatin	Clinical Pharmacokinetics	2003	488
40	The Gut as a Barrier to Drug Absorption	Clinical Pharmacokinetics	2001	475
41	Effects of the Antifungal Agents on Oxidative Drug Metabolism	Clinical Pharmacokinetics	2000	472
42	Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development	Clinical Pharmacokinetics	2009	469
43	Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors	Clinical Pharmacokinetics	1997	455
44	Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children	Clinical Pharmacokinetics	2006	448
45	Pharmacokinetics and Clinical Effectiveness of Methylphenidate	Clinical Pharmacokinetics	1999	446
46	Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban	Clinical Pharmacokinetics	2014	444
47	Clinical Pharmacokinetics of Diazepam	Clinical Pharmacokinetics	1978	441
48	Clinical Pharmacokinetics of Everolimus	Clinical Pharmacokinetics	2004	440
49	Clinical Pharmacokinetics of Theophylline	Clinical Pharmacokinetics	1978	438
50	Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration	Clinical Pharmacokinetics	1999	437

Scientometrics

Overviews

Citing Bodies

Clinical Pharmacokinetics

Top Articles